Although patients with concurrent cardiovascular disease had higher percentages of CD8+ TEMRA cells and CD14++CD16+ intermediate monocytes in their peripheral blood, the differences between groups were relatively small regarding a given immune subset. This evidence concerns the gene CD8A and cardiovascular disorder.